```html

Ulcus vulgaris (Common Ulcer) – A Complete Patient Guide

Overview

Ulcus vulgaris, commonly referred to as a “common ulcer,” is a breach in the mucosal surface of the gastrointestinal (GI) tract, most frequently occurring in the stomach (gastric ulcer) or the first part of the small intestine (duodenal ulcer). These are a subset of peptic ulcer disease (PUD), which also includes erosions and ulcerations caused by acid‑peptic damage.

Peptic ulcers affect roughly 1–2 % of the global population each year, with a higher prevalence in adults aged 40–70 years. In the United States, about 10 million people develop a new ulcer annually, and roughly 250,000 are hospitalized for complications (NIH, 2021). Both sexes are affected, though men have a slightly higher incidence, especially for duodenal ulcers.

Symptoms

Symptoms can be mild and intermittent or severe and continuous. The classic “ulcer pain” is often described as a burning or gnawing sensation.

• Epigastric pain – typically 2–4 hours after meals for duodenal ulcers, or a feeling of fullness/fatigue after eating for gastric ulcers.
• Heartburn or acid reflux – burning sensation rising toward the throat.
• Nausea & vomiting – may contain food particles or, rarely, blood.
• Loss of appetite & weight loss – due to fear of eating.
• Early satiety – feeling full after a small amount of food.
• Bloating or belching.
• Hematemesis – vomiting blood (bright red or “coffee‑ground” appearance).
• Melena – black, tarry stools indicating digested blood.
• Unexplained anemia – identified on routine blood work.
• Fatigue – secondary to chronic blood loss.

Symptoms may improve temporarily after eating (gastric ulcer) or worsen on an empty stomach (duodenal ulcer). However, any sign of bleeding should be considered urgent.

Causes and Risk Factors

Primary Causes

• Helicobacter pylori infection – a gram‑negative bacterium that damages the protective mucosal layer. It is responsible for ~70 % of duodenal ulcers and ~50 % of gastric ulcers (WHO, 2022).
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – ibuprofen, naproxen, aspirin, and selective COX‑2 inhibitors reduce prostaglandin production, weakening mucosal defenses.
• Excess gastric acid secretion – often linked to Zollinger‑Ellison syndrome or chronic H2‑receptor agonist overuse.

Risk Factors

• Age > 45 years (mucosal healing slows with age).
• Male gender (higher duodenal ulcer rates).
• Smoking – nicotine impairs mucosal blood flow and promotes acid secretion.
• Heavy alcohol consumption – irritates the mucosa and increases acid output.
• Chronic stress – may exacerbate acid production, though stress alone rarely causes an ulcer.
• Family history of ulcer disease or H. pylori infection.
• Use of corticosteroids, anticoagulants, or bisphosphonates (increase bleeding risk).
• Severe comorbidities such as chronic kidney disease, liver cirrhosis, or malignancy.

Diagnosis

Accurate diagnosis combines a thorough history, physical exam, and targeted investigations.

Initial Evaluation

• History & Physical Exam – evaluation of pain pattern, medication use, and risk factors.
• Laboratory tests – CBC for anemia, serum electrolytes, liver/kidney function, and H. pylori testing (urea breath test, stool antigen, or serology).

Imaging & Endoscopic Procedures

• Upper gastrointestinal endoscopy (EGD) – gold standard; allows direct visualization, biopsy of suspicious lesions, and hemostasis if bleeding is present.
• Barium swallow / Upper GI series – useful when endoscopy is contraindicated; can demonstrate ulcer crater and surrounding mucosal irregularities.
• CT abdomen – reserved for suspected perforation or complicated ulcer (abscess, fistula).
• Helicobacter pylori testing – urea breath test is > 95 % sensitive and specific; stool antigen is an alternative in children.

Treatment Options

Therapy aims to eradicate the underlying cause, promote mucosal healing, and prevent recurrence.

Pharmacologic Therapy

• Proton‑pump inhibitors (PPIs) – omeprazole, esomeprazole, pantoprazole; 40‑80 mg daily for 4–8 weeks (Cleveland Clinic, 2023).
• Histamine‑2 receptor antagonists (H2 blockers) – ranitidine, famotidine; useful for mild disease or maintenance after PPI course.
• Antibiotic regimens for H. pylori – triple therapy (PPI + clarithromycin + amoxicillin/metronidazole) for 14 days, or quadruple therapy (bismuth + PPI + tetracycline + metronidazole) when resistance is high.
• Protective agents – sucralfate (coats ulcer) or misoprostol (prostanoid analog) especially for NSAID‑induced ulcers.
• Analgesia – acetaminophen preferred; avoid NSAIDs unless absolutely necessary.

Procedural Interventions

• Endoscopic hemostasis – injection of epinephrine, thermal coagulation, or clipping for actively bleeding ulcers.
• Surgical repair – indicated for perforated, refractory, or malignant‑appearing ulcers; options include laparoscopic oversewing or partial gastrectomy.

Lifestyle Modifications

• Avoid smoking and limit alcohol to ≤ 1 drink/day.
• Take NSAIDs with food or switch to COX‑2‑selective agents under physician guidance.
• Eat smaller, frequent meals; avoid late‑night heavy meals.
• Manage stress through relaxation techniques (mindfulness, yoga).

Living with Ulcus vulgaris (common ulcer)

Effective self‑management reduces flare‑ups and promotes long‑term healing.

• Medication adherence – set daily reminders; never stop PPIs abruptly without medical advice.
• Track symptoms – maintain a diary noting pain timing, food intake, and medication use.
• Dietary tips – favor low‑acid, low‑fat foods; include fiber‑rich fruits (banana, apples) and lean proteins.
• Weight management – maintain a healthy BMI (18.5‑24.9) to lessen abdominal pressure.
• Regular follow‑up – repeat endoscopy after 8–12 weeks if symptoms persist or if H. pylori eradication needs confirmation.
• Vaccinations – if on long‑term PPIs, consider vaccinations against Clostridioides difficile and influenza (immune compromise risk).

Prevention

Prevention focuses on risk‑factor modification and early detection.

• Test and treat H. pylori infection, especially before starting chronic NSAIDs.
• Use the lowest effective NSAID dose; consider a PPI co‑prescription for high‑risk patients.
• Quit smoking – counseling or nicotine‑replacement therapy can increase success rates.
• Limit alcohol to moderate levels (≤ 1 drink/day for women, ≤ 2 for men).
• Adopt a balanced diet low in spicy, fried, and highly acidic foods.
• Manage comorbidities (diabetes, hypertension) that may impair mucosal healing.

Complications

If left untreated, ulcers can lead to serious, potentially life‑threatening outcomes.

• Bleeding (hemorrhage) – most common; may manifest as hematemesis or melena.
• Perforation – a hole in the GI wall causing sudden severe abdominal pain and peritonitis; requires emergency surgery.
• Penetration – ulcer extends into adjacent organs (e.g., pancreas), causing localized pain.
• Gastric outlet obstruction – edema or scarring narrows the pylorus, leading to vomiting and weight loss.
• Malignancy – chronic gastric ulcers have a small risk (~1 %) of evolving into gastric cancer; repeat endoscopy is recommended for lesions > 2 cm or atypical appearance.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, American College of Gastroenterology guidelines (2023), peer‑reviewed journals (Gastroenterology, The Lancet).

```